<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01366417</url>
  </required_header>
  <id_info>
    <org_study_id>371.1.04.19.11</org_study_id>
    <nct_id>NCT01366417</nct_id>
  </id_info>
  <brief_title>Topical Antimicrobial Effectiveness Testing</brief_title>
  <official_title>Test for Preinjection Skin Preparation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CareFusion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CareFusion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to measure the antimicrobial effectiveness of
      ChloraPrep One-Step Frepp Applicator.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antimicrobial Efficacy</measure>
    <time_frame>30 seconds after treatment</time_frame>
    <description>Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 30 seconds after a single application of test material relative to the baseline bacterial count.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Antimicrobial Efficacy</measure>
    <time_frame>10 minutes after treatment</time_frame>
    <description>Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 10 minutes after a single application of test material relative to the baseline bacterial count.</description>
  </primary_outcome>
  <enrollment type="Actual">25</enrollment>
  <condition>Antimicrobial Effectiveness</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ChloraPrep One-Step</intervention_name>
    <description>1.5 ml applicator patient preoperative skin preparation</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>70% isopropyl alcohol</intervention_name>
    <description>Curity Alcohol Prep Pads</description>
    <other_name>Positive Control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  in good general health

          -  have skin within 6 inches of the test sites that is free of tattoos, dermatoses,
             abrasions, cuts, lesions or other skin disorders.

        Exclusion Criteria:

        - topical or systemic antimicrobial exposure within 14 days prior to the Screen Visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad H Bashir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Microbiotest</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Microbiotest</name>
      <address>
        <city>Sterling</city>
        <state>Virginia</state>
        <zip>20164</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2011</study_first_submitted>
  <study_first_submitted_qc>June 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2011</study_first_posted>
  <results_first_submitted>February 16, 2012</results_first_submitted>
  <results_first_submitted_qc>July 31, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 31, 2012</results_first_posted>
  <last_update_submitted>August 31, 2012</last_update_submitted>
  <last_update_submitted_qc>August 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>First subject/first visit: May 12, 2011 Last subject/last visit: June 8, 2011</recruitment_details>
      <pre_assignment_details>43 subjects entered screening phase.25 subjects had qualifying treatment day baseline counts and completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ChloraPrep One Step and 70% Isopropyl Alcohol</title>
          <description>All subjects received a single topical treatment with both the test article (ChloraPrep One Step) and the positive control (Isopropyl Alcohol)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Signed Informed Consent</title>
              <participants_list>
                <participants group_id="P1" count="43">Microbial samples were taken from 43 subjects for screening baseline.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Screen Visit</title>
              <participants_list>
                <participants group_id="P1" count="33">33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Treatment Visit</title>
              <participants_list>
                <participants group_id="P1" count="28">28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed the Study</title>
              <participants_list>
                <participants group_id="P1" count="28">treatment baseline microbial counts not available until after treatment; subjects not evaluable</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Discontinued Prior to Treatment</title>
              <participants_list>
                <participants group_id="P1" count="5">5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Excluded From Analysis</title>
              <participants_list>
                <participants group_id="P1" count="3">3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25">25 subjects included in the analysis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ChloraPrep One Step and 70% Isopropyl Alcohol</title>
          <description>All subjects received a single topical treatment with both the test article (ChloraPrep One Step) and the positive control (Isopropyl Alcohol)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36" spread="16.71105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Antimicrobial Efficacy</title>
        <description>Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 30 seconds after a single application of test material relative to the baseline bacterial count.</description>
        <time_frame>30 seconds after treatment</time_frame>
        <population>subjects whose treatment day baseline microbial count met the qualification criteria and completed all assessments.</population>
        <group_list>
          <group group_id="O1">
            <title>ChloraPrep One Step</title>
            <description>All subjects received a single topical application of ChloraPrep One Step.</description>
          </group>
          <group group_id="O2">
            <title>70% Isopropyl Alcohol</title>
            <description>All subjects received a single topical application of 70% Isopropyl Alcohol.</description>
          </group>
        </group_list>
        <measure>
          <title>Antimicrobial Efficacy</title>
          <description>Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 30 seconds after a single application of test material relative to the baseline bacterial count.</description>
          <population>subjects whose treatment day baseline microbial count met the qualification criteria and completed all assessments.</population>
          <units>log 10 colony forming units / cm^2</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.21" spread="0.1332" lower_limit="1.95" upper_limit="2.48"/>
                    <measurement group_id="O2" value="2.25" spread="0.1332" lower_limit="1.99" upper_limit="2.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Hypothesis: ChloraPrep will meet or exceed the 1.0 log reduction in colony forming units/cm^2 at 30 seconds after application.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>2.21</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.133</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.95</ci_lower_limit>
            <ci_upper_limit>2.48</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>hypothesis: 70% Isopropyl Alcohol will meet or exceed 1.0 log 10 colony forming units / cm^2 at 30 seconds after treatment</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>2.25</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.133</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.99</ci_lower_limit>
            <ci_upper_limit>2.51</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Antimicrobial Efficacy</title>
        <description>Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 10 minutes after a single application of test material relative to the baseline bacterial count.</description>
        <time_frame>10 minutes after treatment</time_frame>
        <population>Subjects whose Treatment Day Baseline bacterial counts met qualification criteria</population>
        <group_list>
          <group group_id="O1">
            <title>ChloraPrep One Step</title>
            <description>All subjects received a single topical application of ChloraPrep One Step.</description>
          </group>
          <group group_id="O2">
            <title>70% Isopropyl Alcohol</title>
            <description>All subjects received a single topical application of 70% Isopropyl Alcohol.</description>
          </group>
        </group_list>
        <measure>
          <title>Antimicrobial Efficacy</title>
          <description>Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 10 minutes after a single application of test material relative to the baseline bacterial count.</description>
          <population>Subjects whose Treatment Day Baseline bacterial counts met qualification criteria</population>
          <units>log 10 colony forming units / cm^2</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.65" lower_limit="2.39" upper_limit="2.92"/>
                    <measurement group_id="O2" value="2.60" lower_limit="2.33" upper_limit="2.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Hypothesis: ChloraPrep One Step will meet or exceed 2.0 log 10 reduction at 10 minutes after treatment.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>2.65</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.133</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.39</ci_lower_limit>
            <ci_upper_limit>2.91</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Hypothesis: 70% Isopropyl Alcohol will meet or exceed 2.0 log 10 reduction at 10 minutes after treatment</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>2.60</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.133</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.33</ci_lower_limit>
            <ci_upper_limit>2.86</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>ChloraPrep One Step and 70% Isopropyl Alcohol</title>
          <description>All subjects received a single topical treatment with both the test article (ChloraPrep One Step) and the positive control (Isopropyl Alcohol)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jennifer Raeder-Devens</name_or_title>
      <organization>CareFusion</organization>
      <phone>847-454-4939</phone>
      <email>jennifer.raeder-devens@carefusion.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

